Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of intensive atorvastatin therapy on prostaglandin E2 levels and metalloproteinase-9 activity in the plasma of patients with non-ST-elevation acute coronary syndrome.
Gómez-Hernández A, Sánchez-Galán E, Ortego M, Martín-Ventura JL, Blanco-Colio LM, Tarín-Vicente N, Jiménez-Nacher JJ, López-Bescos L, Egido J, Tuñón J. Gómez-Hernández A, et al. Am J Cardiol. 2008 Jul 1;102(1):12-8. doi: 10.1016/j.amjcard.2008.02.090. Epub 2008 Apr 22. Am J Cardiol. 2008. PMID: 18572029 Clinical Trial.
Atorvastatin reduces the expression of cyclooxygenase-2 in a rabbit model of atherosclerosis and in cultured vascular smooth muscle cells.
Hernández-Presa MA, Martín-Ventura JL, Ortego M, Gómez-Hernández A, Tuñón J, Hernández-Vargas P, Blanco-Colio LM, Mas S, Aparicio C, Ortega L, Vivanco F, Gerique JG, Díaz C, Hernández G, Egido J. Hernández-Presa MA, et al. Atherosclerosis. 2002 Jan;160(1):49-58. doi: 10.1016/s0021-9150(01)00547-0. Atherosclerosis. 2002. PMID: 11755922
Overexpression of COX-2, Prostaglandin E synthase-1 and prostaglandin E receptors in blood mononuclear cells and plaque of patients with carotid atherosclerosis: regulation by nuclear factor-kappaB.
Gómez-Hernández A, Martín-Ventura JL, Sánchez-Galán E, Vidal C, Ortego M, Blanco-Colio LM, Ortega L, Tuñón J, Egido J. Gómez-Hernández A, et al. Atherosclerosis. 2006 Jul;187(1):139-49. doi: 10.1016/j.atherosclerosis.2005.08.035. Epub 2005 Oct 4. Atherosclerosis. 2006. PMID: 16212965
Atorvastatin reduces the expression of prostaglandin E2 receptors in human carotid atherosclerotic plaques and monocytic cells: potential implications for plaque stabilization.
Gómez-Hernández A, Sánchez-Galán E, Martín-Ventura JL, Vidal C, Blanco-Colio LM, Ortego M, Vega M, Serrano J, Ortega L, Hernández G, Tunón J, Egido J. Gómez-Hernández A, et al. J Cardiovasc Pharmacol. 2006 Jan;47(1):60-9. doi: 10.1097/01.fjc.0000194252.38683.68. J Cardiovasc Pharmacol. 2006. PMID: 16424787
Implication of miR-155-5p and miR-143-3p in the Vascular Insulin Resistance and Instability of Human and Experimental Atherosclerotic Plaque.
González-López P, Ares-Carral C, López-Pastor AR, Infante-Menéndez J, González Illaness T, Vega de Ceniga M, Esparza L, Beneit N, Martín-Ventura JL, Escribano Ó, Gómez-Hernández A. González-López P, et al. Among authors: gomez hernandez a. Int J Mol Sci. 2022 Sep 6;23(18):10253. doi: 10.3390/ijms231810253. Int J Mol Sci. 2022. PMID: 36142173 Free PMC article.
53 results